These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9613735)

  • 21. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal waveform of the human pattern VEP: contribution from gamma oscillatory components.
    Sannita WG; Carozzo S; Fioretto M; Garbarino S; Martinoli C
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4534-41. PubMed ID: 17898275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equiluminant red-green and blue-yellow VEPs in multiple sclerosis.
    Sartucci F; Murri L; Orsini C; Porciatti V
    J Clin Neurophysiol; 2001 Nov; 18(6):583-91. PubMed ID: 11779973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parvocellular and magnocellular contributions to the initial generators of the visual evoked potential: high-density electrical mapping of the "C1" component.
    Foxe JJ; Strugstad EC; Sehatpour P; Molholm S; Pasieka W; Schroeder CE; McCourt ME
    Brain Topogr; 2008 Sep; 21(1):11-21. PubMed ID: 18784997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping.
    Juh R; Pae CU; Lee CU; Yang D; Chung Y; Suh T; Choe B
    Neurosci Res; 2005 Jul; 52(3):211-9. PubMed ID: 15927722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease.
    Abdo WF; Bloem BR; Van Geel WJ; Esselink RA; Verbeek MM
    Neurobiol Aging; 2007 May; 28(5):742-7. PubMed ID: 16678934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal responses to repetitive transcranial magnetic stimulation in multiple system atrophy.
    Löscher WN; Stampfer-Kountchev M; Sawires M; Seppi K; Mueller J; Szubski C; Hirnsperger K; Brenneis C; Poewe W; Wenning GK
    Mov Disord; 2007 Jan; 22(2):174-8. PubMed ID: 17133517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal and dichromatic color discrimination measured with transient visual evoked potential.
    Gomes BD; Souza GS; Rodrigues AR; Saito CA; Silveira LC; da Silva Filho M
    Vis Neurosci; 2006; 23(3-4):617-27. PubMed ID: 16962005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatic and achromatic visual evoked potentials in Parkinson's disease.
    Büttner T; Kuhn W; Müller T; Heinze T; Pühl C; Przuntek H
    Electroencephalogr Clin Neurophysiol; 1996 Sep; 100(5):443-7. PubMed ID: 8893662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.
    Sisto D; Trojano M; Vetrugno M; Trabucco T; Iliceto G; Sborgia C
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1264-8. PubMed ID: 15790888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inter-individual differences in the polarity of early visual responses and attention effects.
    Proverbio AM; Del Zotto M; Zani A
    Neurosci Lett; 2007 May; 419(2):131-6. PubMed ID: 17490815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromatic modulation of luminance visual evoked potential latencies in healthy subjects and patients with mild vision disorders.
    Accornero N; Gregori B; Pro S; Scappini G; La Riccia M
    Clin Neurophysiol; 2008 Jul; 119(7):1683-8. PubMed ID: 18455475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.
    Raffel DM; Koeppe RA; Little R; Wang CN; Liu S; Junck L; Heumann M; Gilman S
    J Nucl Med; 2006 Nov; 47(11):1769-77. PubMed ID: 17079809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual-evoked response, pattern electroretinogram, and psychophysical magnocellular thresholds in glaucoma, optic atrophy, and dyslexia.
    Vaegan ; Hollows FC
    Optom Vis Sci; 2006 Jul; 83(7):486-98. PubMed ID: 16840873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The visual system in Parkinson's disease.
    Bodis-Wollner I; Tagliati M
    Adv Neurol; 1993; 60():390-4. PubMed ID: 8420159
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship between contrast adaptation and orientation tuning in V1 and V2 of cat visual cortex.
    Crowder NA; Price NS; Hietanen MA; Dreher B; Clifford CW; Ibbotson MR
    J Neurophysiol; 2006 Jan; 95(1):271-83. PubMed ID: 16192327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEP contrast sensitivity responses reveal reduced functional segregation of mid and high filters of visual channels in autism.
    Jemel B; Mimeault D; Saint-Amour D; Hosein A; Mottron L
    J Vis; 2010 Jun; 10(6):13. PubMed ID: 20884562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luminance and chromatic visual evoked potentials in type I and type II diabetes: relationships with peripheral neuropathy.
    Gregori B; Galié E; Pro S; Clementi A; Accornero N
    Neurol Sci; 2006 Nov; 27(5):323-7. PubMed ID: 17122941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luminance-contrast mechanisms in humans: visual evoked potentials and a nonlinear model.
    Zemon V; Gordon J
    Vision Res; 2006 Nov; 46(24):4163-80. PubMed ID: 16997347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flexibility in spatial and non-spatial feature grouping: an event-related potentials study.
    Nikolaev AR; van Leeuwen C
    Brain Res Cogn Brain Res; 2004 Dec; 22(1):13-25. PubMed ID: 15561496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.